CHOP, a PTEN Foundation Center of Excellence, Hosts PTEN Conference
Published on in CHOP News
As a designated PTEN Center of Excellence, CHOP offers the highest standards in multidisciplinary care.
Cancer Predisposition Program News and Updates
1 - 9 of 9
Two CHOP Physicians Present at PTEN Symposium
Published on in CHOP News
Drs. Adams and MacFarland among select group of conference speakers.
New Treatment Shows Success in High-Risk Solid Tumors
Published on in CHOP News
The CHOP-engineered therapy overcomes common drug resistance and has potential to elicit fewer toxicities than most cancer treatments.
Cancer Predisposition in Children: Increasing Awareness
Published on in Oncology Update
A CHOP program is focused on identifying children who are predisposed to develop cancer and using surveillance testing to detect cancers early.
Streamlining Care for Patients with Neurofibromatosis Type 1
Published on in Cancer Connections
The Neurofibromatosis Multidisciplinary Clinic allows patients with NF1 to see three or more specialists in one day, allowing for a seamless flow of appointments from morning until afternoon.
CHOP Oncologist Chairs AACR Pediatric Cancer Predisposition Workshop
Published on in Cancer Connections, International Update
Since its inception in October 2016, the workshop has created recommendations for the 50 most common syndromes that predispose children to cancer and produced 16 position papers.
Unlocking the Mysteries of Gene Imprinting Disorders
Published on in CHOP News
The Jan. 13 issue of Science magazine looks at Pediatric Geneticist Jennifer Kalish's work with imprinting errors in genes, the rare diseases they cause and links to cancer.
Comprehensive Cancer Gene Panels Now Available in CHOP’s Division of Genomic Diagnostics
Published on in CHOP News
The Division of Genomic Diagnostics at CHOP has launched a series of hereditary and somatic cancer gene panels to facilitate a precision medicine approach to cancer diagnostics.
Why Do Children Develop Cancer?
Published on in CHOP News
CHOP’s Dr. John Maris comments on a just-published major study of genes that raise a child’s risk for cancer, and what this means for counseling families and patients.